started · updated
Assaí reports 55.2% increase in recurring profit for Q3 2026
Assaí reported a 55.2% increase in recurring net income for the third quarter of 2026, reaching R$ 248 million compared to the same period in 2025. The company also announced its fourth share buyback program, a move intended to potentially increase earnings per share and signal management confidence in the company's valuation.
Financial results showed gross revenue rose 2.7% to R$ 21.3 billion, supported by a gross margin of 17.2%. Accounting net income reached R$ 427 million, a 119% increase, which included R$ 179 million in tax credits. The company also reported a reduction in leverage to 2.15x from 3.03x in the previous year, aided by strong operating cash flow and lower debt costs.
Operational highlights include a 2.1% increase in customer traffic, exceeding 40 million customers per month. Additionally, the company is expanding its ecosystem through Assaí Farma, which aims to reach 25 pharmacy units by December, and through the expansion of its private label product range.
Entities
Assaí · Assaí Farma · Belmiro Gomes · CVM